July 28, 2020
HPV vaccines have a favorable benefit-risk profile and carry clinical significance in Japan as well as in the rest of the world, the Pharmaceuticals and Medical Devices Agency (PMDA) said in a review report for MSD’s nine-valent HPV vaccine Silgard...read more